Israel’s largest hospital, Sheba Medical Center in Tel Hashomer – named in Newsweek Magazine’s Top 10 Best Hospitals in the World – announced that $ 110 million had been raised in 2021 by six companies in the hospital’s ARC Innovation Center.
All of the companies are based on technology invented and developed from Sheba, the hospital said in a statement.
The ARC Innovation Center (Accelerate Collaborative Redesign), Led by Professor Eyal Zimlichman, Director of Innovation and Transformation at Sheba, strives to bring new technologies to the hospital and community ecosystem to revolutionize patient care. ARC enables seamless integration between innovators, scientists, startups, top developers, large companies, investors, and universities, all under one roof. The ARC Innovation Center focuses on digital health technologies, including precision medicine, big data, artificial intelligence (AI), predictive analytics, telemedicine and mobile health.
âThe ARC Innovation Center focused on breakthrough and innovative technologies with a primary directive to rethink healthcare. Our commercialization efforts allow us to extend the reach of these technologies and create a large-scale global impact, âsaid Professor Zimlichman.
Sheba startups that have received investments this year include Aidoc, the company that has raised $ 66 million to use AI to analyze medical images; Belkin Laser, the company that raised $ 13.75 million to develop an automated one-second laser treatment for glaucoma; Starget Pharma, the company that has raised $ 10 million to develop products for the diagnosis and targeted treatment of cancer using radioactive radiation; Appen Medical, the company that raised $ 7.6 million to develop a minimally invasive implantable device designed to reduce the risk of stroke in patients with atrial fibrillation; Innovalve Bio Medical, the company that raised $ 7.2 million to develop catheter-based heart valve therapies; and TechsoMed, the company that raised $ 7 million to develop its BioTrace platform, an AI-powered technology that enables physicians to detect and visualize tissue viability using standard commercial ultrasound imaging for thermal ablation procedures.
âThe quality of innovation at Sheba has won the trust of innovators in healthcare and industry. Additionally, the funding of six companies this year is a testament to investor confidence in innovations developed by Sheba, which aim to solve complex clinical challenges and make healthcare systems more efficient, âsaid Dr Sylvie Luria, CEO of Sheba’s Technology Transfer Company, which manages the CRA’s marketing efforts. âReaching $ 1 billion in investments in ARC technologies over a decade is an important milestone, but the impact of those investments in improving healthcare delivery and patient outcomes is exponentially greater. “